Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
116076 trials found · Page 1367 of 5804
-
Could a single burst of magnetic pulses lift depression in autism?
Symptom relief Recruiting nowThis study will assess clinical and behavioral measures along with electroencephalogram (EEG), event-related potentials (ERPS), and eye-tracking (ET) prior to and following a single intermittent Theta Burst Stimulation (iTBS) session to provide preliminary insight into the potent…
Phase: NA • Sponsor: Yale University • Aim: Symptom relief
Last updated Jul 18, 2026 00:00 UTC
-
Money and mind: can financial coaching ease mental health struggles after incarceration?
Disease control OngoingThis proposal will address financial wellbeing, an often overlooked but important factor impacting reentry for justice-involved people with mental health challenges, who are disproportionately Black and Latine. The project will change community level determinants by integrating f…
Phase: NA • Sponsor: Yale University • Aim: Disease control
Last updated Jul 03, 2026 00:00 UTC
-
New eczema drug shows promise in Mid-Stage trial
Symptom relief OngoingThis is a two-part study that will evaluate the safety and efficacy of APG777 in participants with moderate-to-severe Atopic Dermatitis (AD). Part A (Proof-of-concept) and Part B (Dose-regimen Finding) will evaluate the safety and efficacy of various induction and maintenance dos…
Phase: PHASE2 • Sponsor: Apogee Therapeutics, Inc. • Aim: Symptom relief
Last updated Jul 24, 2026 00:00 UTC
-
New hope for stuffy noses: drug trial targets nasal polyps
Disease control Recruiting nowThe main purpose of this study is to evaluate the efficacy and safety of lebrikizumab in participants with chronic rhinosinusitis and nasal polyps treated with intranasal corticosteroids. The study will last about 18 months.
Phase: PHASE3 • Sponsor: Eli Lilly and Company • Aim: Disease control
Last updated Jul 22, 2026 00:00 UTC
-
New drug combo targets Hard-to-Treat cancers with MTAP deletion
Disease control OngoingThis is a first-in-human Phase 1/2, multicenter, open-label study of S095035 as single-agent, or in combination with TNG462 in adult participants with advanced or metastatic solid tumors with homozygous deletion of MTAP who have failed to respond to or have progressed after at le…
Phase: PHASE1, PHASE2 • Sponsor: Servier Bio-Innovation LLC • Aim: Disease control
Last updated Jun 27, 2026 12:37 UTC
-
Experimental Donor-Cell therapy takes aim at tough autoimmune diseases
Disease control OngoingSC291-102 is a Phase 1 study to evaluate SC291 safety and tolerability, preliminary clinical response, cellular kinetics and exploratory assessments for subjects with severe autoimmune diseases.
Phase: PHASE1 • Sponsor: Sana Biotechnology • Aim: Disease control
Last updated Jun 27, 2026 07:59 UTC
-
Smart oxygen machine could prevent dangerous levels in hospital patients
Disease control CompletedThis study is a multicenter randomized controlled trial to determine the effectiveness of a closed loop/autonomous oxygen titration system (O2matic PRO100) to maintain normoxemia (goal range SpO2 90-96%, target 93%) during the first 72 hours of acute injury or illness, compared t…
Phase: NA • Sponsor: University of Colorado, Denver • Aim: Disease control
Last updated Jun 27, 2026 12:24 UTC
-
New study tracks psoriasis drug in Real-World greek patients
Disease control OngoingPsoriasis is a skin disorder wherein skin cells multiply faster than normal, making the skin itchy and look patchy and red. It is caused by an overactive immune system where the body attacks healthy tissue by mistake. The impact of Psoriasis on quality of life can be significant,…
Sponsor: AbbVie • Aim: Disease control
Last updated Jun 27, 2026 09:01 UTC
-
New brain stimulation method could ease depression
Symptom relief CompletedThe BrainsWay Deep Transcranial Magnetic Stimulation (Depp TMS) device is intended for the treatment of depressive episodes in patients suffering from Major Depressive Disorder (MDD). The device technology is based on the application of deep brain TMS by means of repetitive pulse…
Phase: NA • Sponsor: Brainsway • Aim: Symptom relief
Last updated Jun 27, 2026 11:00 UTC
-
New pacemaker technique aims to protect heart function
Disease control Recruiting nowConventional right ventricular pacing (RVP) has been associated with ventricular dyssynchrony and an increased risk of pacing-induced cardiomyopathy, which may lead to worse clinical outcomes. These adverse effects are more pronounced in patients with pre-existing left ventricula…
Phase: NA • Sponsor: Samsung Medical Center • Aim: Disease control
Last updated Jun 27, 2026 11:00 UTC
-
Wheelchair users with MS may gain strength and mobility through tailored exercise
Symptom relief Recruiting nowApproximately 50% of people with multiple sclerosis (MS) use a wheelchair within 30 years of the initial diagnosis. Wheelchair use in MS is often associated with fatigue as a consequence of muscle weakness. Indeed, fatigue, a prevalent consequence of MS, often becomes debilitatin…
Phase: NA • Sponsor: University of Illinois at Chicago • Aim: Symptom relief
Last updated Jul 15, 2026 00:00 UTC
-
Stockings vs. no stockings: huge trial aims to settle clot prevention debate
Prevention Recruiting nowIndividuals attending the hospital to undergo operations are at risk of developing blood clots in the legs, known as deep vein thrombosis (DVT). A clot in the leg can cause swelling, pain, and other long-term problems. If a clot in the leg breaks off and travels to the lungs, it …
Phase: NA • Sponsor: Imperial College London • Aim: Prevention
Last updated Jun 27, 2026 12:00 UTC
-
New vaccine aims to shield kids from 24 pneumococcal strains
⭐️ VACCINE ⭐️ OngoingPhase I clinical trial of 24-valent pneumococcal conjugate vaccine (PCV24) developed by Shanghai Reinovax Biologics Co., LTD will be conducted in children aged 2 Months (Minimum 6 Weeks) to 17 Years . The objective of the study is to evaluate the safety tolerability and immunogen…
Phase: PHASE1 • Sponsor: Shanghai Reinovax Biologics Co.,LTD • Aim: ⭐️ VACCINE ⭐️
Last updated Jun 27, 2026 08:06 UTC
-
New drug could ease constant allergy symptoms
Symptom relief OngoingThe main purpose of this study is to evaluate the efficacy and safety of lebrikizumab in adult participants with perennial allergic rhinitis. Participants can expect study participation to last up to 29.5 months.
Phase: PHASE3 • Sponsor: Eli Lilly and Company • Aim: Symptom relief
Last updated Jul 24, 2026 00:00 UTC
-
New drug could curb binge eating episodes
Disease control Recruiting nowENGAGE (Elucidating TAAR-1, Dopamine, and Norepinephrine in Binge Eating Disorder Using Solriamfetol) is a Phase 3, randomized, double-blind, placebo-controlled, multicenter trial to assess the efficacy and safety of solriamfetol for the treatment of binge eating disorder (BED) i…
Phase: PHASE3 • Sponsor: Axsome Therapeutics, Inc. • Aim: Disease control
Last updated Jun 27, 2026 07:58 UTC
-
Feeding tube placement may improve breathing in preterm babies
Disease control Recruiting nowThe purpose of this study is to determine if postpyloric feedings effectively improve objective measures of pulmonary health in preterm infants with chronic lung disease when compared with nasogastric (NG) feedings. This research will (1) determine the optimal nutritional managem…
Phase: NA • Sponsor: Boston Children's Hospital • Aim: Disease control
Last updated Jul 01, 2026 00:00 UTC
-
New study aims to slash pneumonia rates in sick newborns on ventilators
Prevention Recruiting nowThe aim of this project is to achieve useful, universal and standardized definitions for the diagnosis and prevention of ventilator-associated neumonia in patients in the Neonatal Intensive Care Unit (NICU). To this end, a set of recommendations and best practice protocols have b…
Sponsor: Biobizkaia Health Research Institute • Aim: Prevention
Last updated Jun 27, 2026 07:59 UTC
-
New dressing may speed healing of diabetic foot sores
Disease control Recruiting nowThe goal of this clinical trial is to compare safety and performance of the study device to the current typical NHS standards of care device. The main outcomes it aims to achieve are: Complete wound healing at 12 weeks (100% epithelialised) % Reduction in wound area at 12 weeks…
Phase: NA • Sponsor: Community Pharmacology Services Ltd • Aim: Disease control
Last updated Jun 27, 2026 08:14 UTC
-
Promising drug targets rare chest cancers in new trial
Disease control Recruiting nowThe goal of this clinical trial is to study the effect of sacituzumab govitecan-hziy in adult patients with advanced thymoma and thymic carcinoma after progressing on at least one prior line of therapy. The main question it aims to answer is: • What is the overall response rate…
Phase: PHASE2 • Sponsor: Georgetown University • Aim: Disease control
Last updated Jun 27, 2026 09:00 UTC
-
Triple therapy targets tough brain metastases in lung cancer
Disease control Recruiting nowThis phase I study aims to investigate the safety and efficacy of whole brain low dose radiotherapy (WB-LDRT) combined with ICI and intrathecal chemotherapy for treatment of refractory meningeal metastasis of lung cancer.
Phase: PHASE1 • Sponsor: Sichuan University • Aim: Disease control
Last updated Jun 27, 2026 12:30 UTC